EBP50 immunoreactivity was observed in the apical plasma membrane (Me-EBP50) and/or cytoplasmic compartment (Cyt-EBP50) of epithelial cells during adenoma to carcinoma progression in CRC (Supplementary Figure S2A). This evidence concerns the gene NHERF1 and carcinoma.